Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass

Carcinogenesis

Volumn 31, Issue 5, 2010, Pages 785-793

  Chun, Gina ^a   Bae, Dongsoon ^a   Nickens, Kristen ^a   O'Brien, Travis J ^a   Patierno, Steven R ^a   Ceryak, Susan ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; CHROMIUM; POLO LIKE KINASE 1; PROTEIN TYROSINE PHOSPHATASE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENOTOXICITY; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MITOSIS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; CELL CULTURE; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE;

CDC2 PROTEIN KINASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CHROMIUM; HUMANS; MITOSIS; MUTAGENESIS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 77952310725     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq014     Document Type: Article

References (42)

1. Kastan, M.B. et al. (2004) Cell-cycle checkpoints and cancer. Nature, 432, 316-323.
2. O'Connell, M.J. et al. (2000) The G2-phase DNA-damage checkpoint. Trends Cell Biol., 10, 296-303.
3. Ostman, A. et al. (2006) Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer, 6, 307-320.
4. Chernoff, J. (1999) Protein tyrosine phosphatases as negative regulators of mitogenic signaling. J. Cell. Physiol., 180, 173-181.
5. Furlong, F. et al. (2005) PTPase inhibition restores ERK1/2 phosphorylation and protects mammary epithelial cells from apoptosis. Biochem. Biophys. Res. Commun., 336, 1292-1299.
6. Bae, D. et al. (2008) Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis. Mutat. Res., 660, 40-46.
7. Yamashita, Y. et al. (2001) Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase. J. Biol. Chem., 276, 39012-39020.
8. Masuda, Y. et al. [beta]-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene, 22, 1012-1023.
9. van Vugt, M.A. et al. (2004) Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell, 15, 799-811.
10. van Vugt, M.A. et al. (2004) Checkpoint adaptation and recovery: back with Polo after the break. Cell Cycle, 3, 1383-1386.
11. Smits, V.A. et al. (2000) Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat. Cell Biol., 2, 672-676.
12. Tsvetkov, L. et al. (2005) Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Cell Cycle, 4, 166-171.
13. Toczyski, D.P. et al. (1997) CDC5 and CKII control adaptation to the yeast DNA damage checkpoint. Cell, 90, 1097-1106.
14. Syljuasen, R.G. et al. (2006) Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases. Cancer Res., 66, 10253-10257.
15. Ha, L. et al. (2003) Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem., 278, 17885-17894.
16. Lal, M.A. et al. (2009) AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells. Cell Cycle, 8, 1589-1602.
17. Lansing, T.J. et al. (2007) In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol. Cancer Ther., 6, 450-459.
18. Ha, L. et al. (2004) Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis, 25, 2265-2274.
19. Swanson, R.L. et al. (1999) Overlapping specificities of base excision repair, nucleotide excision repair, recombination, and translesion synthesis pathways for DNA base damage in Saccharomyces cerevisiae. Mol. Cell. Biol., 19, 2929-2935.
20. Bu, Y. et al. (2008) Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology, 74, 198-206.
21. Crosio, C. et al. (2002) Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol., 22, 874-885.
22. van Vugt, M.A. et al. (2005) Getting in and out of mitosis with Polo-like kinase-1. Oncogene, 24, 2844-2859.
23. Golsteyn, R.M. et al. (1995) Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol., 129, 1617-1628.
24. Jang, Y.J. et al. (2002) Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J. Biol. Chem., 277, 44115-44120.
25. Martin, B.T. et al. (2006) Polo-like kinase 1: target and regulator of transcriptional control. Cell Cycle, 5, 2881-2885.
26. Taniguchi, E. et al. (2002) Nuclear translocation of plk1 mediated by its bipartite nuclear localization signal. J. Biol. Chem., 277, 48884-48888.
27. Roshak, A.K. et al. (2000) The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell. Signal., 12, 405-411.
28. Zhang, Z. et al. (2007) Polo-like kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2. Mol. Reprod. Dev., 74, 1247-1254.
29. Lee, K.S. et al. (1997) Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol. Cell. Biol., 17, 3408-3417.
30. Hanahan, D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
31. Chen, W.L. et al. (2005) Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells. Exp. Eye Res., 81, 570-580.
32. Matsumoto, J. et al. (2006) Sodium orthovanadate enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia. J. Pharmacol. Exp. Ther., 318, 982-991.
33. Liu, X. et al. (2006) Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol. Cell. Biol., 26, 2093-2108.
34. Barr, F.A. et al. (2004) Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol., 5, 429-440.
35. Ellinger-Ziegelbauer, H. et al. (2000) Ste20-like kinase (SLK), a regulatory kinase for polo-like kinase (Plk) during the G2/M transition in somatic cells. Genes Cells, 5, 491-498.
36. van Vugt, M.A. et al. (2001) Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM-or ATR-dependent fashion. J. Biol. Chem., 276, 41656-41660.
37. Lee, K.S. et al. (1998) Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc. Natl Acad. Sci. USA, 95, 9301-9306.
38. Porter, L.A. et al. (2003) Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog. Cell Cycle Res., 5, 335-347.
39. O'Brien, T.J. et al. (2003) Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res., 533, 3-36.
40. Bridgewater, L.C. et al. (1998) Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinog., 23, 201-206.
41. Trenz, K. et al. (2008) Plx1 is required for chromosomal DNA replication under stressful conditions. EMBO J., 27, 876-885.
42. O'Brien, T.J. et al. (2002) Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Repair (Amst.), 1, 617-627